Cargando…

COVID-19 vaccine development, production and regulatory oversight in African countries

Detalles Bibliográficos
Autores principales:	Makenga, Geofrey, Booy, Robert, Oloo, Paul Ndaya, Auerbach, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511670/ https://www.ncbi.nlm.nih.gov/pubmed/36188025 http://dx.doi.org/10.2471/BLT.22.287958

Ejemplares similares

Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction
por: Makenga, Geofrey, et al.
Publicado: (2019)

The imperative for regulatory oversight of large language models (or generative AI) in healthcare
por: Meskó, Bertalan, et al.
Publicado: (2023)

Addressing production gaps for vaccines in African countries
por: Ekström, Anna Mia, et al.
Publicado: (2021)

FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation
por: Milko, Laura V., et al.
Publicado: (2019)

Regulatory Oversight and Safety of Probiotic Use
por: Venugopalan, Veena, et al.
Publicado: (2010)

Tigers, black swans, and unicorns: The need for feedback and oversight
por: Houck, Max M.
Publicado: (2019)

Medical device regulation and oversight in African countries: a scoping review of literature and development of a conceptual framework
por: Nasir, Naima, et al.
Publicado: (2023)

Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13(®)) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS
por: Makenga, Geofrey, et al.
Publicado: (2021)

Overcoming COVID-19 in West African countries: is herd immunity an option?
por: Ilesanmi, Olayinka Stephen, et al.
Publicado: (2020)

Tobacco supply and demand strategies used in African countries
por: Crosbie, Eric, et al.
Publicado: (2021)

Genetic Alterations That Do or Do Not Occur Naturally; Consequences for Genome Edited Organisms in the Context of Regulatory Oversight
por: Custers, René, et al.
Publicado: (2019)

Financial Regulation and Compliance: How to Manage Competing and Overlapping Regulatory Oversight, + Website
por: Kotz, H
Publicado: (2015)

Overcoming regulatory gaps in biological materials oversight by enhancing IBC protocol review
por: Rainer, David, et al.
Publicado: (2016)

FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012)

Road map for research on responsible artificial intelligence for development (AI4D) in African countries: The case study of agriculture
por: Gwagwa, Arthur, et al.
Publicado: (2021)

International regulatory considerations pertaining to the development of stem cell-based veterinary medicinal products
por: Jeon, Byung-Suk, et al.
Publicado: (2021)

Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
por: Cherian, Neil, et al.
Publicado: (2023)

2276 Development of the expanded access oversight committee at Michigan Medicine
por: Weatherwax, Kevin, et al.
Publicado: (2018)

Monitoring and oversight in critical care research
por: Lavery, James V, et al.
Publicado: (2004)

The Trouble With Too Much Board Oversight
por: Hoitash, Udi
Publicado: (2013)

Review of the Processes for FDA Oversight of Drugs, Medical Devices, and Combination Products
por: Sweet, Burgunda V., et al.
Publicado: (2011)

How are regulatory oversight organisations using long-term care performance indicators: a qualitative descriptive study in 10 high-income countries
por: Poldrugovac, Mircha, et al.
Publicado: (2023)

The Chronic Cholera Situation in Africa: Why Are African Countries Unable to Tame the Well-Known Lion?
por: Olu, Olushayo Oluseun, et al.
Publicado: (2023)

Scientists versus Regulators: Precaution, Novelty & Regulatory Oversight as Predictors of Perceived Risks of Engineered Nanomaterials
por: Beaudrie, Christian E. H., et al.
Publicado: (2014)

Dietary supplements and nutraceuticals market growth during the coronavirus pandemic – Implications for consumers and regulatory oversight
por: Lordan, Ronan
Publicado: (2021)

Factors facilitating sustainable scientific partnerships between developed and developing countries
por: Kunert, Karl J, et al.
Publicado: (2020)

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
por: Maure, Christine G, et al.
Publicado: (2014)

Investigating barriers to the protective efficacy provided by rotavirus vaccines in African infants
por: Bines, Julie E.
Publicado: (2021)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective
por: Baylor, Norman W., et al.
Publicado: (2022)

Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank
por: White, R. G., et al.
Publicado: (2018)

Dengue virus and SARS-CoV-2 Co-infection dynamics: An emerging threat among African countries
por: Oladipo, Habeebullah Jayeola, et al.
Publicado: (2022)

Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases
por: Kumar, Velayudhan Mohan, et al.
Publicado: (2021)

Bringing Opportunity Oversight Onto the Board's Agenda
por: Leonard, Frank
Publicado: (2013)

Corporate governance, board oversight, and CEO turnover
por: Laux, Volker
Publicado: (2014)

Four Fallacies and an Oversight: Searching for Martian Life
por: Rummel, J.D., et al.
Publicado: (2017)

US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016)

Rigorous review and editorial oversight of clinical preprints
por: Zaidi, Mone, et al.
Publicado: (2021)

Oversight and Management of Women with Psoriasis in Childbearing Age
por: Bucur, Ștefana, et al.
Publicado: (2022)

Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience
por: So, Anthony D, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_o9902fpvpbh558h2nvq9rs4c5c